In many model organisms, diffuse patterning of cell wall peptidoglycan synthesis by the actin 2 homolog MreB enables the bacteria to maintain their characteristic rod shape. In Caulobacter 3 crescentus and Escherichia coli, MreB is also required to sculpt this morphology de novo.
]. One way to study rod formation is to generate spheroplasts that lack 2 a cell wall, without which bacteria swell and become spherical ( Fig. 1) can cells rebuild their wall, but they are also able to recover rod morphology. In E. coli, sphere-5 to-rod reversion requires MreB to direct peptidoglycan synthesis in the appropriate locations 6 [Billings et al. 2014 ]. This means that the same machinery that maintains rod morphology can 7 also drive de novo rod morphogenesis. Thus E. coli morphology is thought to be a hardwired 8 property of the cell that depends on MreB [Billings et al. 2014 ]. plays a key role in yeast morphology [Drees et al. 1995; Gunning et al. 1997 ].
6
DivIVA marks the tips of mycobacterial cells, and is found in higher concentrations at the older, like MreB, might function in de novo rod morphogenesis in addition to its known role in shape 3 maintenance. Here we show that DivIVA is required for population-wide reversion of 4 mycobacterial spheres to rods. There is also a tight spatiotemporal association between DivIVA 5 location and site of rod extrusion. We hypothesized that DivIVA may contribute to de novo 6 morphogenesis via a mechanism similar to the one it uses to maintain existing rod shape. Using 7 metabolic labeling paired with high resolution microscopy, we find that assembly of 8 peptidoglycan and the mycomembrane occurs but is disorganized upon DivIVA depletion.
9
Furthermore, repletion of the protein is required to re-localize envelope assembly. Taken 10 together, our data suggest that DivIVA programs mycobacterial morphology by organizing 11 envelope synthesis. 
13

Results and Discussion
7
The DivIVA-eGFP strain is viable, indicating that the tagged, essential protein is functional. We 8 first confirmed loss of fluorescently-labeled peptidoglycan and of rod morphology following the 9 enzymatic digestion procedure (Figs. S1 and 2B). We then allowed the cells to recover in the 10 absence or presence of ATC. At 0, 24 and 48 hours of recovery, cells were blindly scored as 11 one of four morphologies: sphere, early transition, late transition, or rod. The DivIVA-eGFP 12 spheroplast population exposed to ATC was significantly slower to revert to rod morphology 13 than the one that was not ( Fig. 2A, 2B ). By contrast, there was no ATC-dependent difference in 14 population outgrowth when the spheroplasts were generated from wildtype M. smegmatis.
16
We considered two, non-mutually exclusive explanations for the observation that rod formation 17 was delayed but not blocked in the presence of ATC. First, DivIVA might contribute to, but not 18 be required for, sphere-to-rod transition at the population level. Alternatively, or additionally, 19 degradation of ATC or the appearance of ATC-insensitive escape mutants may have allowed a 20 DivIVA-eGFP-positive subpopulation to outcompete the parental genotype and reform rods. To 21 distinguish between these possibilities, we took advantage of the fact that DivIVA is tagged with 22 eGFP and thus easily detected in single cells. We first asked whether ATC addition was 23 associated with eGFP absence. While there is generally a close, inverse correlation between 24 ATC and eGFP at early depletion time points, at 24 hours only 39% of ATC-treated bacteria 25 (n=121) remained eGFP-negative (compared to 4% of untreated bacteria, n=271). If DivIVA is indeed required for the sphere-to-rod transition, we hypothesized that, regardless of the 1 underlying cause of DivIVA repletion in the presence of ATC, preservation of spherical 2 morphology should only occur when DivIVA-eGFP is absent. Indeed, we find that eGFP-3 negative bacilli are significantly more likely than their eGFP-positive counterparts to remain 4 spherical at 24 hours (Fig. 2C ). The close correlation between the absence of DivIVA-eGFP and 5 the apparent retention of spherical morphology raised the possibility that DivIVA is required for 6 creation of cell shape in addition to the maintenance of this phenotype. 
4
Whether spherical mycobacteria were generated by cell wall digestion or by depletion of DivIVA, 5 our data suggested that the presence of the protein correlated with population-wide transition to 6 rod shape. Despite our efforts to obtain a homogenous starting population of spheres, we noted 7 that 5-20% of cells retain rod shape following enzymatic cell wall digestion or DivIVA depletion.
8
We considered the possibility that outgrowth of this subpopulation might account for the 9 population-wide shift from spherical cells to rods, rather than shape alterations of individual 
13
The 10 or 24 hour window for shape recovery following DivIVA depletion or spheroplasting,
14
respectively, left open the possibility that the sphere-to-rod transitions occur at the population 15 level but not in single cells. Accordingly, we used time-lapse microscopy to track morphogenesis 16 in single DivIVA-eGFP cells rendered spherical by ATC incubation. After ATC washout, the 17 protein first appeared dispersed throughout the cell at ~14 hours then coalesced into a single 18 focus. A new, DivIVA-marked pole protruded from this site ( Fig. 2F , Movie S1). Organisms 19 whose shape is maintained by MreB have been shown to achieve de novo rod morphogenesis 20 by different strategies. Gradual cell thinning and elongation, discrete polar protrusion, and 21 division prior to rod regeneration have all been observed in sphere-to-rod transition of such 
23
However, we observed that mycobacterial DivIVA-mediated sphere-to-rod reversion is only 24 accomplished via protrusion of a new localized growth pole. Such protrusions occurred in 37%
25
of the population (n=52). None of the remaining 63% of spherical cells exhibited visible eGFP foci ( Fig. S5 ). Therefore, we hypothesized that at least some of the failure to generate rod 1 shape was due to cell death, rather than the inability of DivIVA to initiate polar growth. We 2 tested the viability of DivIVA-depleted M. smegmatis with propidium iodide, which only 3 penetrates cells with compromised plasma membranes. Indeed we found that 36% of DivIVA- 
12
Distinguishing between these possibilities is critical for understanding how DivIVA orchestrates 13 cell envelope assembly and morphogenesis.
15
We sought to clarify the nature of DivIVA regulation by improving the spatial and temporal 
16
TAMRA fluorescence was no longer polar, and either partially or completely surrounded the cell 17 ( Fig. 3B, 3D ). After 8 hours of depletion, the cells developed large bulges that were evenly 18 labeled, and after 12 hours, they were primarily spherical, bounded by homogenous labeling 19 ( Fig. 3B, 3D) . Some of the eGFP-negative spheres had labeled septa (Fig. 3B) , supporting the 
21
Continued incorporation of alkDADA in the absence of DivIVA suggested that in addition to 22 periplasmic remodeling of peptidoglycan, cytoplasmic synthesis also persists. To further 23 distinguish between the two processes, we repeated the labeling experiment after pre-treating 24 with a broad-spectrum inhibitor of periplasmic remodeling, imipenem. We observed similar patterns of fluorescence ( Fig. S6 ) Taken together, our data demonstrate that peptidoglycan 1 assembly continues in the absence of DivIVA but in a disorganized fashion.
3
Assembly of the three, covalently-bound layers of the mycobacterial envelope-peptidoglycan, 4 arabinogalactan and the mycomembrane-is likely to be spatially coincident. In support, the 
19
Spatial and temporal coincidence of DivIVA localization, concentrated peptidoglycan assembly 20 and rod extrusion from spherical M. smegmatis. Our data suggest that mycobacterial cell 21 envelope assembly is persistent but disorganized in the absence of DivIVA (Fig. 3B, 3D, 4B ).
22
DivIVA-depleted cells are also unable to maintain their shape (Fig. 2D, 2E) (Fig. 2F ). We hypothesized that the difference in outgrowth 4 phenotype might be related to the ability of DivIVA to concentrate zones of peptidoglycan 5 synthesis. We depleted DivIVA-eGFP for 16 hours until spheres were generated. We then 6 washed away ATC and labeled the cells with alkDADA at the end of a 10 hour recovery period.
7
The tips of the nascent protrusions were marked with alkDADA labeling, which in turn 8 colocalized with DivIVA-eGFP foci (Fig. 5A ). When outlines of recovering cells were used to 9 generate relative fluorescence intensity profiles as they correspond to cell geometry, we found 10 that parts of the cell that were still spherical had little or no visible eGFP and dimmer, more 11 homogenous alkDADA-derived fluorescence (Fig. 5B ). Additionally, we found that the intensity 12 peaks for both channels were spatially correlative. Our data are consistent with a model in 13 which DivIVA helps to establish and maintain shape in mycobacteria by nucleating cell envelope 14 synthesis.
16
Summary of Results
17
The ability of a bacterium to readily regenerate its shape suggests that morphology is not simply 
